
The people
New LEadership
Meet Mark Kirton
Mark Kirton, an ALS patient since 2018 and esteemed ALS Action Canada board member, has spearheaded awareness and advocacy efforts since his diagnosis and, recently, within the NHL community. His dedication has activated prominent athletes and media representatives to endorse helping eradicate ALS, including Wayne Gretzky, Darryl Sittler, Wendel Clark, among several others. His determination has led to the remarkable alliance of all 32 NHL teams, which have united to amplify ALS advocacy and raise significant funds for research.
Leigh Naturkach Appointed as New Executive Director of ALS Action Canada
Leigh Naturkach is a values-based non-profit leader and consultant, with over twenty-five years experience in charitable, social justice, health and gender equity sectors and grassroots movements.
Previous to joining ALS Action Canada as Executive Director, Leigh was the Executive Director at the Mosaic Institute for Harnessing Diversity, a national charity focused on education, dialogue, training and research to reduce prejudice and advance social cohesion. Her consultant practice has served clients such as the Royal Ontario Museum, and numerous small non-profits in strategy, development, and inclusive practices.
She has held multiple leadership roles in health advocacy and equity organizations, including Women’s College Hospital Foundation, driving millions to advance healthcare equity and innovation, as well as fundraising for AIDS Committee of Toronto, supporting and empowering people living with, at risk for and affected by HIV.
During her tenure at Canadian Women’s Foundation, Leigh led the Women Moving Women campaign, raising $6.25 million to fuel economic development programs for women facing economic and social barriers. She also raised funds for girls leadership and violence prevention programs, as well as was the manager of violence prevention and healthy teen relationship programs.
Leigh’s volunteer experience over two decades in Board of Director roles has included serving organizations such as Dying with Dignity Canada, Canadians for Choice, and Arrabon House for at risk girls. Her frontline volunteer experience has served Hospice Toronto, Journey Home Hospice, Ernestine’s Women’s Shelter, Scarborough Women’s Centre, a number of dog rescue and foster organizations across Ontario, and many others.
Leigh has formal education and background in media and marketing, and worked for Corus Entertainment in production, programming, and marketing for nearly ten years. She has earned certification and engages in communities of practice as a death doula, in community engagement and leadership, as well as is a certified dog trainer with nearly 5,000 hours of volunteer fostering, rescue and boarding experience.
The actions and funding decisions of the ALS Super Fund are guided by members of the Advisory Council. The Advisory Council is composed of leading minds in ALS from around the world, including neurologists, researchers, clinicians, and charity representatives. When funds are disbursed to charities, the Super Fund will report results back to donors, building transparency and confidence that the ALS Super Fund is catalyzing change.
Meet the Advisory Council
Don Wright
ALS Action Canada Chairman, Senior Public Sector Executive
Dr. Colleen O’Connell
Physiatrist, Prof. Dalhousie University Faculty of Medicine, Medical Director and Research Chief at Horizon’s Stan Cassidy Centre, Fredericton, New Brunswick
Dr. Angela Genge
Neurologist/Dir. ALS Centre of Excellence for Research & Patient care at McGill University, Montréal, Québec
Dr. Lorrne Zinman
Neurologist/Associate Scientist/Dir. Sunnybrook Health Sciences Centre, Toronto Ontario
Dr. David Taylor
VP of Science/Research at ALS Canada, Toronto, Ontario
Dr. Wendy Johnston
Neurologist/professor at the University of Alberta, Edmonton Alberta
Dr. Lawrence Korngut
Neurologist & Dir. of the Calgary Neuromuscular Program, Calgary Alberta
Dr. Andrew Darke
ALSAC PAL
Rick Zwiep
ALSAC PAL
Matthew Brown
ALSAC PAL
Cali Orsulak
ALS CAL
Dr. Merit Cudkowicz
Director of the Healey & AMG Centre for ALS, chief of neurology at Massachusetts General hospital
Dr. Ammar Al-Chalabi
Prof. of Neurology & Complex Disease Genetics at Institute of Psychiatry, Psychology & Neuroscience at King's College London England